Associate Chief Physician, Department of Oncology, Shanghai Sixth People's Hospital, 2007
MD from Anhui Medical University, 1995
PhD from Suzhou Univercity
Director, Department of Oncology, Shanghai Eighth People's Hospital
Tian Wang , Dexing Wang , Lian Zhang, Ping Yang, Jing Wang, Qi Liu, Fei Yan and Feng Lin. The TGFbeta-miR-499a-SHKBP1 pathway induces resistance to EGFR inhibitors in osteosarcoma cancer stem cell-like cells.Journal of experimental & clinical cancer research : CR 2019;38:226.
Zhang L, Yang P, Wang J, Liu Q, Wang T, Wang Y, Lin F. MiR-22 regulated T cell differentiation and hepatocellular carcinoma growth by directly targeting Jarid2.American journal of cancer research. 2021;11(5):2159-2173.
Dexing Wang,Guowei Qian,Jin Wang,Tian Wang,Lian Zhang,Ping Yang,Feng Lin. Visfatin is involved in the cisplatin resistance of osteosarcoma cells via upregulation of Snail and Zeb1.Cancer biology & therapy 2019;20:999-1006.
Ping Yang,Lian Zhang,Tian Wang,Yaling Wang,Tu Zhiquan,Feng Lin. Doxorubicin and Edelfosine Combo-Loaded Lipid-Polymer Hybrid Nanoparticles for Synergistic Actincacer Effect Against Drug-Resistant Osteosarcoma.OncoTargets and Therapy.2020:13 8055-8067.
Tian Wang, Feng Lin, Yujing Huang , Guowei Qian , Wenxi Yu2, Haiyan Hu2, Tong Ji, Lina Tang, Yang Yao. The Combination of Anlotinib and Gemcitabine/Docetaxel in Patients with Metastatic Osteosarcoma Who Have Failed Standard Chemotherapy.Cancer Management and Research 2022:14 2945–2952
01/01/2018-12/31/2021
Shanghai Xuhui District Medical Summit Discipline Construction Project, ¥ 600,000, SHXH201710,Prevention and comprehensive diagnosis and treatment of bone metastasis cancer and its complications
Role: Project leader
01/01/2020-12/31/2024
Shanghai Xuhui District Medical Research Project , ¥100,000,SHXH201709,The regulatory mechanism of klf8 transcription factor in the initiation of lung metastasis in osteosarcoma
Role: Project leader